Mini International Neuropsychiatric Interview 7.0 PDF Download: A Short and Accurate Diagnostic Tool

Another factor that may be important in accounting for cases of depression among patients with COPD is the method used to identify depression. Despite numerous reports of a higher prevalence of depression in patients with COPD, it is important to recognize that most studies analyze the symptoms of depression without emphasizing the diagnosis [5, 8]. Therefore, this study aimed to analyze the influence of depression using a diagnostic tool, the mini international neuropsychiatric interview plus (MINI), rather than an analysis of the symptoms, to determine the effect of depression on functional capacity and quality of life among patients with COPD.

mini international neuropsychiatric interview 7.0 pdf download

Download File: https://urlgoal.com/2vCIaU

Some details of the present study that may help in understanding the results are described as follows. This study used a structured interview for the diagnosis of depression, performed by only one trained psychiatrist, who was blinded to the evaluation results from the functional tests performed by the physiotherapist or the pulmonary function results performed by the pulmonologist. In addition to the structured interview, this study also administered a quality of life questionnaire specific to COPD. Moreover, a broad-scoped assessment of functional capacity was performed by a physical therapist who had no knowledge regarding the results of the psychiatric evaluation. This study used a population from a clinical setting in a cross-sectional study. Some limitations exist in this study. Because this was a cross-sectional study, it was not possible to establish causal relationships to support the existence of a temporal sequence between the exposure factor and the subsequent development of the disease. Additionally, this work was carried out with a sample of convenience, which may limit the ability of our results to be generalized.

Psychiatric morbidity was defined as having at least one of the disorders included in the Mini International Neuropsychiatric Interview (MINI) Version 7 for Diagnostic and Statistical Manual 5th Edition (DSM-5). MINI is a short diagnostic structured interview, developed for Axis I psychiatric disorders and it has been shown to be reliable compared to the Structured Clinical Interview for DSM (SCID) and the Composite International Diagnostic Interview (CIDI), but with a shorter administration time [11]. It has been used in Kenya in a study by Ndetei et al. after adaptation and adoption [12]. For this study, a written permission to use and translate the MINI was granted by the author, Dr. Sheehan.

Before starting data collection activities, a pilot survey was conducted to get the enumerators acquainted with the study procedures including listing process, how to approach the household, obtaining participant consent, ensuring confidentiality of the study participants, and to evaluate study instruments. When the main survey started, participants were included in the survey if they fulfilled the inclusion criteria including being a Rwandan citizen residing in Rwanda, aged 14 to 65 years old, and having lived in the enumeration area for at least 6 months. Males and females with limited capacity of communication that prevent the interviewer from oral administration of the surveys were excluded from the study. Genocide survivors who took part in the general population survey were excluded from participating in the study for the genocide survivors.

We are conducting a randomized, double-blind, placebo-controlled trial of oxytocin-enhanced motivational interviewing group therapy (MIGT). Oxytocin or placebo 40 IU is administered intranasally in conjunction with six, weekly MIGT sessions. We will recruit 50 MSM, initiating treatment for MUD from specialized community health programs in San Francisco, CA, USA. Individuals will be randomized (1:1) to receive six, weekly sessions of MIGT with or without oxytocin. Our primary outcome is session attendance. Other outcomes of interest include: measures of group cohesion, anxiety, psychophysiology, and stimulant craving and use.

Interested individuals will undergo initial screening for eligibility using a brief, structured telephone interview. To determine full eligibility, participants will attend an initial in-person assessment where informed written consent will be obtained by study staff prior to any study procedures. See Fig. 1 for study flow diagram. Sociodemographic variables will be collected by a clinical assessor, including: age, gender identification, sexual orientation using the Kinsey Scale [61], race, education, employment status, annual income, living situation, relationship status, HIV status, medical history, and medications. The subsections of Major Depressive Disorder, Manic Episodes, Alcohol Use Disorder, Substance Use Disorders, and Psychotic Disorders of The Mini International Neuropsychiatric Interview (MINI) 7.0.0 [62] and the Suicide subsection from the Structured Clinical Interview for DSM-5 (SCID-5) [63] will be administered. Participants will provide a urine sample and undergo additional clinical interviews and self-assessment questionnaires at this initial visit. A study clinician will perform a brief medical examination, including examination of the nasal mucosa.

The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview, developed jointly by psychiatrists and clinicians in the United States and Europe, for DSM-IV and ICD-10 psychiatric disorders. With an administration time of approximately 15 minutes, it was designed to meet the need for a short but accurate structured psychiatric interview for multicenter clinical trials and epidemiology studies and to be used as a first step in outcome tracking in nonresearch clinical settings. The authors describe the development of the M.I.N.I. and its family of interviews: the M.I.N.I.-Screen, the M.I.N.I.-Plus, and the M.I.N.I.-Kid. They report on validation of the M.I.N.I. in relation to the Structured Clinical Interview for DSM-III-R, Patient Version, the Composite International Diagnostic Interview, and expert professional opinion, and they comment on potential applications for this interview.

Short and ultra-short prototypes were developed for Major Depressive Disorder (MDD), Generalised Anxiety Disorder (GAD), Panic Disorder (PD) and Social Phobia (SP). Prototypes were compared to typical short and ultra-short self-report screening scales, such as the Centre for Epidemiology Scale, CES-D and the GAD-7, and their short forms. The Mini International Neuropsychiatric Interview (MINI) version 6 [1] was used as the gold standard for obtaining clinical criteria through a telephone interview. From a population sample, 225 individuals who endorsed a prototype and 101 who did not were administered the MINI. Receiver operating characteristic (ROC) curves were plotted for the short and ultra short prototypes and for the short and ultra short screening scales.

The Mini International Neuropsychiatric Interview (MINI) version 6 [1] was used as the gold standard for obtaining clinical criteria for comparing the sensitivity and specificity of the prototypes to the scales. The MINI is a brief interview that has strong concordance with diagnoses based on the Structured Clinical Interview for DSM-III-R (SCID) or the Composite International Diagnostic Interview (CIDI) [30]. Only the modules assessing depression, social phobia, panic disorder and generalised anxiety disorder (GAD) were administered, corresponding to each of the prototypes being assessed. Exclusion criteria including drug use, medication use and alternative diagnosis (for GAD) were not assessed, to maintain comparability to the prototypes and scales used in the survey.

Surveys included the short and the ultra short versions of the prototypes, the four standard scales and their short forms (CES-D, GAD-7, SPIN and PDSS-SR), questions on background characteristics, and a consent form for clinical interview. These surveys were mailed to the 14,000 potential participants, along with information about the study. A subsample of respondents was then selected for a clinical interview. An algorithm for clinical interview selection was designed prior to the study, aiming to administer clinical interviews with all of the respondents with high scores on the prototypes and some of the participants with low scores according to a weekly quota system. A random sample of respondents who did not identify with any of the prototypes was also selected for interview. Only participants who provided a telephone number and consented to be interviewed were contacted. Participants who identified at any level with the schizophrenia prototype (n = 64) were excluded from having a phone interview.

The clinical interviews (MINI) were conducted over the telephone by a team of four clinical psychology postgraduate students and one trainee clinical psychologist, all of whom received three hours of training in the administration of the clinical interview, including a videoconference with the authors of the MINI. From the 2,976 respondents, 1,257 consented and were eligible for a clinical interview. A total of 349 participants who endorsed a prototype and 129 who did not endorse a prototype were selected for clinical interviews. Of those selected, interviews were completed with 225 endorsers (64.5%) and 101 non-endorsers (78.3%). Up to seven call attempts were made in order to contact each of the selected participants, with a two-week window given to make contact after the survey was returned. Clinical interviewers were blinded to the survey responses of the interviewees. The sampling procedure is shown in Figure 1.

We used a validated Norwegian translation of the Life Events Checklist (LEC) to assess exposure to potentially traumatic events (Halvorsen and Stenmark 2010). The LEC is a 17-item self-report questionnaire, but we administered it as part of the structured interview. The LEC has good temporal stability and reliability (Gray et al. 2004).

The International Personality Disorder Examination (IPDE) Questionnaire and Interview was also used for assessment [35]. The IPDE is a semistructured interview used to assess personality disorders. It has been approved by the World Health Organization and has been translated into Spanish [36]. In this study, it was used to identify exclusion criteria of schizotypal and borderline personality disorders. It also has a brief self-applied screening questionnaire, in which, using dichotomous answers to questions, the individual describes his or her usual behavior in the past 5 years. This questionnaire provides the interviewer with quick information about which personality disorder is likely to be present. The corresponding module of the IPDE interview is then administered, which allows for the confirming or ruling out of the diagnosis. 2ff7e9595c